JR

Joachim Rothe

Partner bei EQT Life Sciences

Greater Munich Metropolitan Area

VC
Investor

Invests in

Locations:

Munich, Germany

  • Min Investment:

    $11,000,000.00

  • Max Investment:

    $65,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Venture Capital
Venture Financing
Private Equity
Mergers & Acquisitions
Due Diligence
Start-ups
Deal Sourcing
Biotechnology
Early Stage Companies
Early Stage Investment
Technology Transfer
Lifesciences
Seed Capital

Education

Lists including Joachim

AT
AS
AT
AH

All Series A Investors

14748 people

Investments

Binx Health

Series B

Total Funding: $280M

DNA Script

Series B

Total Funding: $470M

Innovative Molecules

Series A

Total Funding: $24M

Nouscom

Series B

Total Funding: $140M

Luxendo

Series A

Total Funding: $15M

Cellerix

Series B

Total Funding: $120M

U3 Pharma

Series Unknown

Total Funding: $34M

Work Experience

EL
EQT Life Sciences

2022

  • Partner

    2022

Life Sciences Partners (LSP)

2002 - 2022

  • General Partner

    2002 - 2022

MC
MPM Capital

1997 - 2001

  • Principal, Head of Europe

    1997 - 2001

M&
McKinsey & Company

1995 - 1997

  • Engagement Manager

    1995 - 1997

Imperial Cancer Research Fund

1993 - 1994

  • Postdoctoral Research Fellow

    1993 - 1994

R
Roche

1989 - 1993

  • Scientist

    1989 - 1993